{"product_id":"scheie-eye-anniversary-meeting-2024","title":"Penn Medicine Annual Scheie Eye Anniversary Meeting 2024","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3\u003ePenn Medicine Annual Scheie Eye Anniversary Meeting 2024\u003c\/h3\u003e\n\u003cstrong\u003e9 videos + 31 pdfs, size: 3.56 GB\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eSaturday, March 16, 2024, 7:30 AM – 5:00 PM, Kozart Auditorium\/Scheie Eye Institute\/PPMC Saturday, March 16, 2024, Philadelphia, PA\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThis course is designed to provide the audience with the most current clinical advances in ophthalmology and highlight on-going research taking place at the Scheie Eye Institute in the fields of glaucoma, anterior segment, retinal diseases, genetics, oculoplastic surgery, neuro-ophthalmology and ocular pathology. Evidence-based guidelines are an important foundational element to anchor a population health approach that advances eye and vision health.\u003cbr\u003e\u003cbr\u003eFirst, they provide guidance based on sound, objective evidence that a variety of care providers can use to improve the uniformity of messaging about, and the quality of, patient care. Second, they establish a baseline from which to measure improvement in care processes and patient health outcomes. Third, they promote a culture of accountability by enabling performance comparisons and encouraging the uniform adoption of best practices.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – NEUROLOGY, OPHTHALMOLOGY\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003ch3 class=\"activitysectionbold\"\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003ch4\u003e\u003cem\u003eAfter completing this activity, participants should be able to:\u003c\/em\u003e\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eIdentify and manage complicated oculoplastic cases in the adult and pediatric age group\u003c\/li\u003e\n\u003cli\u003eReview treatment options for various diseases of the retina including macular degeneration\u003c\/li\u003e\n\u003cli\u003eClarify new methods of diagnosis and management of various diseases of the cornea\u003c\/li\u003e\n\u003cli\u003eDiscuss new diagnostic modalities and ocular imaging techniques\u003c\/li\u003e\n\u003cli\u003eReview insights into the diagnosis and management of glaucoma\u003c\/li\u003e\n\u003cli\u003eDiscuss diagnostic challenges and management of various neuro-ophthalmic diseases\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eA Diagnostic Anomaly.mp4\u003cbr\u003eA Diagnostic Anomaly.pdf\u003cbr\u003eA Mass-ing Discovery.mp4\u003cbr\u003eA Mass-ing Discovery.pdf\u003cbr\u003eA Refractory Case of Optic Disc Edema.mp4\u003cbr\u003eA Refractory Case of Optic Disc Edema.pdf\u003cbr\u003eAll Hyphemas Are Not What They Heme.mp4\u003cbr\u003eAll Hyphemas Are Not What They Heme.pdf\u003cbr\u003eAn Unusual Case of Diplopia.mp4\u003cbr\u003eAn Unusual Case of Diplopia.pdf\u003cbr\u003eBuilding a Better Bleb.mp4\u003cbr\u003eBuilding a Better Bleb.pdf\u003cbr\u003eCase Presentation- “A Congenital Cataract”.mp4\u003cbr\u003eCase Presentation- “A Congenital Cataract”.pdf\u003cbr\u003eCharacterization of Thyroid Eye Disease Reactivation Following First Teprotumumab Infusions.mp4\u003cbr\u003eCharacterization of Thyroid Eye Disease Reactivation Following First Teprotumumab Infusions.pdf\u003cbr\u003eComparison of Number and Type of Ophthalmic Surgeries in Patients Treated with Teprotumumab versus Those who were Treated with Steroids Orbital Radiation Alone.mp4\u003cbr\u003eComparison of Number and Type of Ophthalmic Surgeries in Patients Treated with Teprotumumab versus Those who were Treated with Steroids Orbital Radiation Alone.pdf\u003cbr\u003eCorrelation of Objective Ocular Alignment and Subjective Diplopia After Teprotumumab in Patients with Thyroid Eye Disease (TED).pdf\u003cbr\u003eDefying the Odds.mp4\u003cbr\u003eDefying the Odds.pdf\u003cbr\u003eDevelopmental Changes of the Nasolacrimal Duct After Stent Placement in a Rabbit Model.mp4\u003cbr\u003eDevelopmental Changes of the Nasolacrimal Duct After Stent Placement in a Rabbit Model.pdf\u003cbr\u003eEvolving Role of Endothelial Keratoplasty.mp4\u003cbr\u003eEvolving Role of Endothelial Keratoplasty.pdf\u003cbr\u003eGene Therapy for LCA 5.mp4\u003cbr\u003eGene Therapy for LCA 5.pdf\u003cbr\u003eLong-term Outcomes of Pediatric Glaucoma, Drainage Implants.mp4\u003cbr\u003eLong-term Outcomes of Pediatric Glaucoma, Drainage Implants.pdf\u003cbr\u003eManaging Unhappy Postop Patients- How to Fix without Making it Worse.mp4\u003cbr\u003eManaging Unhappy Postop Patients- How to Fix without Making it Worse.pdf\u003cbr\u003eMulitomodal Imaging in Uveitis.mp4\u003cbr\u003eMulitomodal Imaging in Uveitis.pdf\u003cbr\u003eNow You See Me.Now You Don’t!.mp4\u003cbr\u003eNow You See Me.Now You Don’t!.pdf\u003cbr\u003eOptimizing Systemic Factors in Normal Tension Glaucoma.mp4\u003cbr\u003eOptimizing Systemic Factors in Normal Tension Glaucoma.pdf\u003cbr\u003eOrbital Apocrine Hidrocytoma.mp4\u003cbr\u003eOrbital Apocrine Hidrocytoma.pdf\u003cbr\u003eOverview of Clinical Trials in Inherited Retinal Degeneration.mp4\u003cbr\u003eOverview of Clinical Trials in Inherited Retinal Degeneration.pdf\u003cbr\u003ePoor Man’s LASIK.mp4\u003cbr\u003ePoor Man’s LASIK.pdf\u003cbr\u003ePrevalence of Novel Antibodies in a Prospective Cohort of Dry Eye Patients.mp4\u003cbr\u003ePrevalence of Novel Antibodies in a Prospective Cohort of Dry Eye Patients.pdf\u003cbr\u003eSEI24_Agenda.pdf\u003cbr\u003eShould Systemic Steroids be Given for Massive Suprachoroidal Hemorrhage..mp4\u003cbr\u003eShould Systemic Steroids be Given for Massive Suprachoroidal Hemorrhage..pdf\u003cbr\u003eSierra Leone Southern Eye Institute.mp4\u003cbr\u003eSierra Leone Southern Eye Institute.pdf\u003cbr\u003eThe “P-Score- A New Reference-image Clinical Scale for Vascular Change in ROP.mp4\u003cbr\u003eThe “P-Score- A New Reference-image Clinical Scale for Vascular Change in ROP.pdf\u003cbr\u003eTreating Severe Photoreceptor Degeneration and Genetic Therapies.pdf\u003cbr\u003eVitreoretinopathy in CTNNB1 Syndrome.mp4\u003cbr\u003eVitreoretinopathy in CTNNB1 Syndrome.pdf\u003cbr\u003eWelcome.mp4\u003cbr\u003eWho is Providing Your Health Care. Standards for Patient Safety.mp4\u003cbr\u003eWho is Providing Your Health Care. Standards for Patient Safety.pdf\u003cbr\u003e“Please Stop the World Shaking!”.mp4\u003cbr\u003e“Please Stop the World Shaking!”.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954435166306,"sku":"MED-AMB03438","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/5967329052148745041_121.jpg?v=1779376634","url":"https:\/\/meducourse.com\/products\/scheie-eye-anniversary-meeting-2024","provider":"Meducourse","version":"1.0","type":"link"}